Press Releases Orasis Starts US Phase 3 Studies of Presbyopia Eye Drop The company is enrolling about 600 participants with presbyopia. Published 4 weeks ago on November 1, 2020 By INVISION Staff Share Tweet (PRESS RELEASE) HERZLIYA, ISRAEL — Orasis Pharmaceuticals, an emerging ophthalmic pharmaceutical company focused on developing an innovative pharmaceutical solution for the treatment of presbyopia symptoms, announced the initiation of NEAR-1 and NEAR-2 Phase 3 clinical studies in the U.S., evaluating its novel eye drop candidate designed to improve near vision for people with presbyopia. “We are excited to move into the final stage of clinical development of our corrective eye drop while preparing for pre-commercialization,” said Elad Kedar, CEO of Orasis. “Presbyopia, the inability to focus on near objects, is a progressive, ubiquitous condition that affects almost two billion people above the age of 40 all around the world. Orasis is committed to making near vision clear again for people who live with this condition. Our proprietary eye drop formulation was designed to achieve the optimal balance between efficacy, safety, and comfort. Promising results from our well powered Phase 2b study, along with the recent Series C funding, have paved a promising path for us to advance our product candidate through Phase 3 development and pre-commercialization efforts. We look forward to providing this novel and non-invasive option for presbyopia to eyecare providers and patients.” The NEAR-1 and NEAR-2 Phase 3 studies are multi-center, double-masked, parallel-group clinical trials in the U.S. enrolling approximately 600 participants with presbyopia to further evaluate the efficacy and safety of Orasis’ eye drop candidate. For more information about the studies, visit NEAR-1 and NEAR-2. Related Topics:Orasis click to Comment(Comment) Up Next Prevent Blindness Declares November as Diabetes-Related Eye Disease Month Don't Miss CVS Pharmacy Launches QuickRenew Advertisement SPONSORED VIDEO Only Varilux lenses are backed by the patented LiveOptics™ R&D process which tests our lenses on real wearers in real-life conditions to ensure sharper, seamless vision. With Varilux lenses, your patients may even forget they’re wearing glasses. But they’ll never forget it was you who recommended them. SPONSORED BY ESSILOR See Why Choosing Varilux® Matters You may like Think You’re Having a Bad Day? ECPs Told Us Their Biggest Screwups This Seattle Practice Turned A Muralist Loose On Its Walls — With Stunning Results 19 Images That Will Change the Way You Think About Optical Lighting Promoted Headlines Make Them Yours: Specialty Coatings/Tints North American Coating Laboratories Introducing EssilorLuxottica 360 Essilor American Eyes 2020 — Safilo’s Celebration of U.S. Eye Care Professionals Continues Safilo Advertisement Latest Trending Videos The Big survey12 hours ago Think You’re Having a Bad Day? ECPs Told Us Their Biggest Screwups Best of the Best1 day ago This Seattle Practice Turned A Muralist Loose On Its Walls — With Stunning Results Photo Gallery2 days ago 19 Images That Will Change the Way You Think About Optical Lighting Press Releases2 days ago Prevent Blindness Declares December as ‘Give the Gift of Sight Month’ Columns4 days ago Increase Medicaid Patient Engagement With 3 Simple Steps Photo Gallery6 days ago Hilary Swank in Silhouette TMA Frames … and More Celebrity Eyewear Picks Headlines3 weeks ago Report: U.S. Vision to Lay Off 299 Workers Headlines3 weeks ago Pennsylvania Expands Optometrists’ Scope of Practice The Big survey1 week ago These 14 Industry Traditions Need to Die, ECPs Say Photo Gallery3 weeks ago Check Out These 17 Eye-Catching Optical Murals Headlines4 weeks ago Video: Florida Man Invents Robot to Place Contact Lenses Headlines4 weeks ago Video: Some Retailers Board Up Due to Election Unrest Fears Headlines1 month ago Video: Car Crashes Into Optometry Office; 4 Taken to Hospital Sponsored Content3 months ago Introducing EssilorLuxottica 360 Sponsored Webinars3 months ago Introducing Varilux® Comfort Max Lenses Advertisement SubscribeBULLETINS Get the most important news and business ideas for eyecare professionals every weekday from INVISION. Advertisement Most Popular Photo Gallery6 days ago Hilary Swank in Silhouette TMA Frames … and More Celebrity Eyewear Picks Benchmarks6 days ago How 6 Eyecare Businesses Get the Word Out to the Right People — On a Budget The Big survey5 days ago 35 Time Management Hacks From Your Fellow ECPS The Big survey1 week ago ECPs Share COVID-19’s Life Lessons Columns4 days ago Increase Medicaid Patient Engagement With 3 Simple Steps Products1 week ago 9 Brands That Ensure You’ll Look Good From Your Head to Your Toes The Big survey6 days ago More Than 60% of ECP Businesses Expect Earnings to Fall This Year Mark Hinton1 week ago Are You Effectively Connecting with Patients Before, During and After Their Office Visit?